FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

HCA

HCA HealthcareNYSE · Health Care Facilities · Health Care
Previous close
430.43
Change
+6.61 / +1.56%
FinDog View
Bullish
52-Week Range
353.99 – 556.52
P/E (TTM)
13.4
Forward P/E
12.7
Based on consensus earnings for the next 12 months
Market Cap
$93.2B
1M
+6.28%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.4M / 1.4M
0.95× average

Price History

Closing price · USD1M6M1Y5Y
350400450500550FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 17.41M6M1Y5Y
1012.51517.52022.52025-092025-122026-032026-062026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-14$20.2B7.59 / 7.54+4.19%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-24$19.1B7.15 / 7.21+3.08%Pending
FY2025 Q4
Quarter ended 2025-12
2026-01-27$75.6B8.01 / 7.53−2.89%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-24—— / —+4.66%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-25—— / —+1.86%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-01—— / —+1.44%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 14 of its 5-year rangeCheap
5-year range 12.4 – 19.1 · Median 15.9
Last 4 quarters: $9.1B in buybacks + $682M in dividends, 10.53% of market cap combined
P/E (TTM)
13.4
P/B
—
P/S
1.2
Dividend Yield
0.95%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.0% on average on the first trading day after, rising 5 times
Most recent +4.19%
Volatility & Correlation
1-year beta 0.18 · Correlation with S&P 500 0.07Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q119.11+4.3%——1.620.907.15
FY2025 Q419.51+6.7%——1.880.878.09
FY2025 Q319.16+9.6%——1.643.136.96
FY2025 Q218.61+6.4%——1.653.036.83
FY2025 Q118.32+5.7%——1.610.666.45
FY2024 Q418.29+5.7%——1.441.275.66
FY2024 Q317.49+7.9%——1.272.324.88
FY2024 Q217.49+10.3%——1.460.695.53
FY2024 Q117.34+11.2%——1.591.355.93
FY2023 Q417.30+11.7%——1.611.525.92
FY2023 Q316.21+8.3%——1.081.333.91
FY2023 Q215.86+7.0%——1.191.234.29

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
HCAHCA Healthcare$93.2B13.4+4.3%—+6.28%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare